Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
Published
02/25/2021 at 5:15 am
Views & Downloads
1
Related Resources
ASTA Draft Risk Profile Comments
Positions & Comments
Allergens & Other Food Safety Issues
3/3/2014
ASTA issued a comment to the Food and Drug Administration (FDA) in March 2014 regarding the FDA's Draft Risk Profile on Pathogens and Filth in Spice.
NCFIA Comments Regarding FDA/CBP Coordination on Prior Notice Requirements
Positions & Comments
Allergens & Other Food Safety Issues
5/11/2004
NCFIA issued comments to the Food and Drug Administration in May 2004 regarding joint FDA and Customs and Border Protection plans for increasing integration and assessing the coordination of prior notice timeframes.